戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  marker of risk for CL development caused by Leishmania braziliensis.
2 hway were abundant in skin lesions caused by Leishmania braziliensis.
3 atment for cutaneous leishmaniasis caused by Leishmania braziliensis.
4 Trypanosoma brucei and to a lesser extent in Leishmania braziliensis.
5 ecies of Leishmania: Leishmania infantum and Leishmania braziliensis.
6 a for cutaneous leishmaniasis (CL) caused by Leishmania braziliensis.
7                     Patients coinfected with Leishmania braziliensis and helminths took longer to hea
8 d associated with drug-treatment failures in Leishmania braziliensis and Leishmania guyanensis infect
9 .5%) of small RNAs derived from LRV1 in both Leishmania braziliensis and Leishmania guyanensis, mappi
10 iparasitic results against Trypnosoma cruzi, Leishmania braziliensis and Leishmania infantum were not
11 g more than 300 telomere-derived clones from Leishmania braziliensis and Leishmania major, a conserve
12                         Dogs from an area of Leishmania braziliensis and Leishmania peruviana endemic
13 teins from Lutzomyia intermedia, a vector of Leishmania braziliensis, and evaluated the seroreactivit
14 patients with cutaneous leishmaniasis due to Leishmania braziliensis are CD4(+)CD25(-)CD127(-/low)FOX
15                                              Leishmania braziliensis are intracellular parasites that
16 s for the care of patients with CL caused by Leishmania braziliensis, because screening for and treat
17                         Leishmania major and Leishmania braziliensis both cause cutaneous leishmanias
18                               The control of Leishmania braziliensis by individuals with subclinical
19  and found that human patients infected with Leishmania braziliensis develop dysbiotic skin microbiot
20 nt of cutaneous leishmaniasis (CL) caused by Leishmania braziliensis in Brazil with pentavalent antim
21 ue, genome-wide transcriptional profiling of Leishmania braziliensis-infected cutaneous lesions and n
22 ripheral blood mononuclear cells (PBMC) from Leishmania braziliensis-infected human patients have dem
23             We have previously reported that Leishmania braziliensis infection can activate murine de
24               Cutaneous leishmaniasis due to Leishmania braziliensis infection is an inflammatory dis
25 ross-protection against Leishmania major and Leishmania braziliensis infection.
26                                              Leishmania braziliensis infections are often associated
27  with cutaneous leishmaniasis (CL) caused by Leishmania braziliensis is associated with high levels o
28       Cutaneous leishmaniasis (CL) caused by Leishmania braziliensis is characterized by a strong Th1
29 al leishmaniasis, caused in South America by Leishmania braziliensis, is difficult to cure by chemoth
30 urrently, TriTrypDB integrates datasets from Leishmania braziliensis, L. infantum, L. major, L. taren
31 eened in vitro against Leishmania infantum , Leishmania braziliensis , Leishmania guyanensis , Leishm
32 the three complexes of New World Leishmania (Leishmania braziliensis, Leishmania mexicana, and Leishm
33                                              Leishmania braziliensis M2903 contains a highly amplifie
34 ntly enhanced infection with doses of >10(4) Leishmania braziliensis parasites in BALB/c mice.
35 ified between 1992 and 1998 in an area where Leishmania braziliensis transmission is endemic; 8 of th

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。